Schistosomiasis is a major neglected tropical disease. Control of schistosomiasis currently
relies on a single drug, praziquantel, and despite its efficacy against the all schistosome …

Background Mycobacterium tuberculosis infection is thought to induce oxidative stress. N-
acetyl-cysteine (NAC) is widely used in patients with chronic pulmonary diseases including …

Schistosomiasis represents a world health major problem affecting more than 206 million
people worldwide. Up to date, praziquantel (PZQ) is the sole chemotherapeutic agent used …

Probiotics contribute to the integrity of the intestinal mucosa and preventing dysbiosis
caused by opportunistic pathogens, such as intestinal helminths. Bacillus cereus GM …

Schistosomiasis is a tropical parasitic disease, in which the major clinical manifestation
includes hepatosplenomegaly, portal hypertension, and organs fibrosis. Clinically, treatment …

The activity of β-lapachone (3, 4-dihydro-2, 2-dimethyl-2H-naphthol [1, 2-b] pyran-5, 6-dione,
β-lap) against different stages of Schistosoma mansoni was investigated in mice. Mice …

Schistosomiasis control is widely dependent on a single drug, praziquantel (PZQ). The
potential for development of resistance to PZQ has justified the search for new alternative …

Schistosomiasis represents a serious public health problem, a disease for which the
circulating cathodic antigen (CCA) is a relevant biomarker. Quantum dots (QDs) are …

Infections caused by Schistosoma haematobium and Opisthorchis viverrini are classified as
Group 1 biological carcinogen and it has been postulated that parasites produce oxysterol …

Schistosomiasis is one of the world's most prevalent parasitic diseases and cause of
morbidity and mortality. The present study was designed to investigate the immune …